What does TA stand for?
TA stands for Therapeutic Area
This definition appears very frequently
and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of TA
Samples in periodicals archive:
Historical sales performance (2007-2011) for each country-- Historical sales performance (2007-2011) for each region-- Sales forecast (2012-2017) for each country-- Sales forecast (2012-2017) for each region-- Sales performance of key manufacturers for each country (2007-2011)-- Sales performance of key therapeutic areas for each country (2007-2011)-- Country wise sales breakup for each region (2007-2011)-- Country wise sales breakup forecast for each region (2012-2017)
The comprehensive prescription data in China will present you a clear picture of the competition landscape of Chinese drug market for each therapeutic area (such as cancer, hypertension, diabetes, to name a few) and the market potential for your company's product(s) that already marketed in China or if you are planning to bring your drugs to the China market.
Which trends are unique to a single therapeutic area, or to a unique market within a therapeutic area?
Windhover Information has announced the Top 10 Licensable Projects for its upcoming Therapeutic Area Partnerships event.
As a parent of two children with cystic fibrosis, I am doubly grateful for Inspire's excellent work in this therapeutic area.
March 8 /PRNewswire/ -- Pharmaceutical Institute, a leading provider of specialized training solutions for the pharmaceutical and biotech industry and a subsidiary of Campbell Alliance, today announced the release of Therapeutic Area Essentials(TM), a comprehensive suite of more than 155 therapeutic area e-courses covering diagnosis, cause, and treatment for over 40 disease states.
There are few industry professionals that can be considered experts in our therapeutic area of fibrosis.
R&D Portfolio Analysis: Therapeutic Area Focus of the Top 50 Pharmaceutical Companies, a new DR Report published by Decision Resources, studies the overall patterns of R&D activity among the top 50 pharmaceutical companies globally, then provides a cohort-by-cohort analysis (Top 10, Top 11- 20, etc.